Searchable abstracts of presentations at key conferences in endocrinology

ea0085p92 | Thyroid | BSPED2022

Multisystem involvement in severe primary hypothyroidism

Baioumi Alaa , Kolenova Alzbeta , Avatapalle Bindu

A 10-year-old female was referred because of prolonged bleeding lasting for a week following a tooth extraction. She had menarche at the age of 9 years, and since then, she used to have regular heavy periods lasting for over two weeks every month. She had low haemoglobin, prolonged APTT and low von Willebrand antigen level. Therefore, she was diagnosed with von Willebrand disease. At the same time, she was found to have a high TSH and low free T4. She was referred to the paedi...

ea0095p15 | Bone | BSPED2023

Stuve Wiedemann syndrome – case series of 3 cases

Ramalingam Bharani Anand , Avatapalle Bindu , Williams Georgina , Pryce Rebekah

Introduction: Stuve–Wiedemann Syndrome (SWS) is a rare genetic condition with autosomal recessive inheritance characterized by the association of typical facial appearances, skeletal manifestations including bowed legs and dysautonomia. Only two patients with long survival have been reported in 2001. We report three children whose periodic clinical evolution could be observed in our hospital until the age of 9 years. We report a case of SWS with associate...

ea0085oc10.6 | Oral Communications 10 | BSPED2022

A comparative study observing the association between graves’ disease and the covid-19 pandemic in children

Uppal Kamalpreet , Warner Justin , Williams Georgina , Pryce Rebekah , Hawkes Davida , Bindu Avatapalle Hima

Background: Coronavirus 2019 (Covid-19), an infectious disease caused by SARS-CoV-2 virus has been linked to autoimmunity. Graves’ disease (GD) is a common subtype of paediatric hyperthyroidism and an autoimmune condition, where antibodies stimulate the thyroid-stimulating hormone receptor on the thyroid gland to produce excess thyroid hormone. Although, paediatric GD is rare, incidence have risen before the pandemic, and this rise has accelerated since the Covid-19 pande...

ea0030p10 | (1) | BSPED2012

A case of Noonan syndrome with a SHOC2 mutation associated with cortical and trabecular osteopenia and early onset fragility fractures

Avatapalle Bindu , Padidela Raja , Clayton-Smith Jill , Freemont Tony , Burkitt-Wright Emma , Mughal Zulf

Introduction: Noonan syndrome (NS) (OMIM 163950) is an autosomal dominant clinically heterogeneous disorder characterised by multisystem involvement. Mutations in genes in the RAS/MAP signaling pathways are known to be responsible for ~70% of cases of NS. We report an infant with NS with early onset fragility fractures.Case report: A 15-month-old male infant with a history of atopic eczema, sparse hair on the scalp, slow motor development, feeding diffic...

ea0027p77 | (1) | BSPED2011

Octreotide treatment for congenital hyperinsulinism can cause hepatitis

Avatapalle Bindu , Rigby Lindsey , Patel Leena , Ehtisham Sarah , Skae Mars , Padidela Raja , Banerjee Indraneel , Clayton Peter

Introduction: Congenital hyperinsulinism (CHI) is a rare condition of dysregulated insulin secretion causing hypoglycaemia. Oral Diazoxide is used as first line therapy for CHI. In those who are Diazoxide unresponsive, subcutaneous Octreotide is used as second line treatment. Octreotide has recognised side effects of biliary stasis. Additionally, we report hepatitis as a complication of Octreotide therapy in a child with CHI.Case report: A neonate with C...

ea0027p81 | (1) | BSPED2011

An audit of diazoxide prescriptions in children with congenital hyperinsulinism: preliminary recommendations

Dimitriu Alma Iulia , Avatapalle Bindu , Rigby Lindsey , Banerjee Indraneel , Patel Leena

Introduction: Congenital hyperinsulinism (CHI) is characterised by abnormally regulated and excessive insulin secretion by pancreatic β cells. First line management includes an oral suspension of Diazoxide but a standardised formulation is not universally employed. Anecdotal evidence suggests that different formulations can alter the management of glucose levels. Lack of glucose control can lead to permanent brain damage and adversely affect neuro development.<p class...

ea0045p47 | Miscellaneous/other | BSPED2016

Longitudinal changes in bone density and body composition in post-pubertal adolescents treated with GnRH analogues in a Gender Identity Development Service

Tseretopoulou Xanthippi , Alvi Sabah , Avatapalle Bindu , Walker Jenny , Carruthers Paul , Mushtaq Talat

Introductions: Gender Identity Disorder (GID) occurs when a person’s gender identity differs from their biological sex, causing distress (gender dysphoria). GID presenting in childhood can dissipate at puberty. If it persists, they may progress to physical interventions. This involves the use of a GnRH analogue (GnRHa) for one year followed by cross sex hormones.Methods: As part of the clinical assessments, adolescents have body composition measurem...

ea0030oc2.5 | Oral Communications 2 | BSPED2012

Abnormal neurological and developmental outcomes in children with persistent and spontaneously resolving congenital hyperinsulinism

Avatapalle Bindu , Shah Sajni , Pryce Megan , Nicholson Jacqueline , Rigby Lindsey , Caine Louise , Didi Mohammed , Ehtisham Sarah , Patel Leena , Skae Mars , Padidela Raja , Banerjee Indraneel , Clayton Peter

Introduction: Neuroglycopaenia is recognised with abnormal neurology and development (Ab Dev) in 26–44% of children with persistent congenital hyperinsulinism (P-CHI). The prevalence of Ab Dev in spontaneously resolving CHI (R-CHI) is not known. We aimed to investigate Ab Dev in R-CHI and P-CHI children in a contemporary cohort.Methods: All children (n=67) were assessed for Ab Dev in the domains of speech, language, motor and vision, and cate...

ea0030p44 | (1) | BSPED2012

Risk factors for short term post-operative complications after pancreatectomy for congenital hyperinsulinism

Avatapalle Bindu , Albazi Mariam , Lance Charlotte , Rigby Lindsey , Ehtisham Sarah , Skae Mars , Patel Leena , Padidela Raja , Bruce Jim , Craigie Ross , Banerjee Indraneel , Clayton Peter

Introduction: Pancreatectomy may be necessary to treat hypoglycaemia due to congenital hyperinsulinism (CHI) following failure of medical management. Post-operative complications including infection and persistent hypoglycaemia have been reported after pancreatectomy, but factors predictive of these have not been recognised.Aims: To investigate if early factors or the time to surgery predict risk of CHI surgical complications and hypoglycaemia in the 6 m...